Loading…

Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease

Diabetic kidney disease (DKD), characterized by increased urinary microalbumin levels and decreased renal function, is the primary cause of end-stage renal disease. Its pathological mechanisms are complicated and multifactorial; Therefore, sensitive and specific biomarkers are needed. Urinary exosom...

Full description

Saved in:
Bibliographic Details
Published in:World journal of diabetes 2024-01, Vol.15 (1), p.92-104
Main Authors: Han, Lu-Lu, Wang, Sheng-Hai, Yao, Ming-Yan, Zhou, Hong
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3
cites cdi_FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3
container_end_page 104
container_issue 1
container_start_page 92
container_title World journal of diabetes
container_volume 15
creator Han, Lu-Lu
Wang, Sheng-Hai
Yao, Ming-Yan
Zhou, Hong
description Diabetic kidney disease (DKD), characterized by increased urinary microalbumin levels and decreased renal function, is the primary cause of end-stage renal disease. Its pathological mechanisms are complicated and multifactorial; Therefore, sensitive and specific biomarkers are needed. Urinary exosome originate from diverse renal cells in nephron segments and partially mirror the pathological changes in the kidney. The microRNAs (miRNAs) in urinary exosome are remarkably stable and highly tissue-specific for the kidney. To determine if urinary exosomal miRNAs from diabetic patients can serve as noninvasive biomarkers for early DKD diagnosis. Type 2 diabetic mellitus (T2DM) patients were recruited from the Second Hospital of Hebei Medical University and were divided into two groups: DM, diabetic patients without albuminuria [urinary albumin to creatinine ratio (UACR) < 30 mg/g] and DKD, diabetic patients with albuminuria (UACR ≥ 30 mg/g). Healthy subjects were the normal control (NC) group. Urinary exosomal miR-145-5p, miR-27a-3p, and miR-29c-3p, were detected using real-time quantitative polymerase chain reaction. The correlation between exosomal miRNAs and the clinical indexes was evaluated. The diagnostic values of exosomal miR-145-5p and miR-27a-3p in DKD were determined using receiver operating characteristic (ROC) analysis. Biological functions of miR-145-5p were investigated by performing Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Urinary exosomal expression of miR-145-5p and miR-27a-3p was more upregulated in the DKD group than in the DM group (miR-145-5p: 4.54 ± 1.45 1.95 ± 0.93, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.71 ± 0.76, < 0.05) and the NC group (miR-145-5p: 4.54 ± 1.45 1.55 ± 0.83, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.10 ± 0.51, < 0.001). The exosomal miR-145-5p and miR-27a-3p positively correlated with albuminuria and serum creatinine and negatively correlated with the estimated glomerular filtration rate. miR-27a-3p was also closely related to blood glucose, glycosylated hemoglobin A1c, and low-density lipoprotein cholesterol. ROC analysis revealed that miR-145-5p had a better area under the curve of 0.88 [95% confidence interval (CI): 0.784-0.985, < 0.0001] in diagnosing DKD than miR-27a-3p with 0.71 (95%CI: 0.547-0.871, = 0.0239). Bioinformatics analysis revealed that the target genes of miR-145-5p were located in the actin filament, cytoskeleton, and extracellular exosome and were involved in the p
doi_str_mv 10.4239/wjd.v15.i1.92
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2922446327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2922446327</sourcerecordid><originalsourceid>FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3</originalsourceid><addsrcrecordid>eNpNkElPwzAQhS0EolXpkSvKkUuCtzjxsarYpAokRM_WJHaQ28QpdlvIv8dV2eYyM2-enjQfQpcEZ5wyefOx0tme5JklmaQnaEwkL1PJ8vL03zxC0xBWOBbPhWDyHI1YyQgruRyjYemtAz8k5rMPfQdt0tna9y9Ps5TwPM03CTj9p9ECUha1eptASFzvrNtDsHuTaAtvrg9bWyeVjUF-bXxImt4fLpU56GurnRniHgwEc4HOGmiDmX73CVre3b7OH9LF8_3jfLZIayroNgWSF1ISgSvaAMdAjNE1cEmxZqAF1SUthIG8KQUDrBtcVdDUugCK67Khmk3Q9TF34_v3nQlb1dlQm7YFZ_pdUFRSyrlgtIjW9GiN34bgTaM23sZXBkWwOgBXEbiKwJUlStLov_qO3lWd0b_uH7zsC2LufdE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2922446327</pqid></control><display><type>article</type><title>Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease</title><source>PubMed Central</source><creator>Han, Lu-Lu ; Wang, Sheng-Hai ; Yao, Ming-Yan ; Zhou, Hong</creator><creatorcontrib>Han, Lu-Lu ; Wang, Sheng-Hai ; Yao, Ming-Yan ; Zhou, Hong</creatorcontrib><description><![CDATA[Diabetic kidney disease (DKD), characterized by increased urinary microalbumin levels and decreased renal function, is the primary cause of end-stage renal disease. Its pathological mechanisms are complicated and multifactorial; Therefore, sensitive and specific biomarkers are needed. Urinary exosome originate from diverse renal cells in nephron segments and partially mirror the pathological changes in the kidney. The microRNAs (miRNAs) in urinary exosome are remarkably stable and highly tissue-specific for the kidney. To determine if urinary exosomal miRNAs from diabetic patients can serve as noninvasive biomarkers for early DKD diagnosis. Type 2 diabetic mellitus (T2DM) patients were recruited from the Second Hospital of Hebei Medical University and were divided into two groups: DM, diabetic patients without albuminuria [urinary albumin to creatinine ratio (UACR) < 30 mg/g] and DKD, diabetic patients with albuminuria (UACR ≥ 30 mg/g). Healthy subjects were the normal control (NC) group. Urinary exosomal miR-145-5p, miR-27a-3p, and miR-29c-3p, were detected using real-time quantitative polymerase chain reaction. The correlation between exosomal miRNAs and the clinical indexes was evaluated. The diagnostic values of exosomal miR-145-5p and miR-27a-3p in DKD were determined using receiver operating characteristic (ROC) analysis. Biological functions of miR-145-5p were investigated by performing Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Urinary exosomal expression of miR-145-5p and miR-27a-3p was more upregulated in the DKD group than in the DM group (miR-145-5p: 4.54 ± 1.45 1.95 ± 0.93, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.71 ± 0.76, < 0.05) and the NC group (miR-145-5p: 4.54 ± 1.45 1.55 ± 0.83, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.10 ± 0.51, < 0.001). The exosomal miR-145-5p and miR-27a-3p positively correlated with albuminuria and serum creatinine and negatively correlated with the estimated glomerular filtration rate. miR-27a-3p was also closely related to blood glucose, glycosylated hemoglobin A1c, and low-density lipoprotein cholesterol. ROC analysis revealed that miR-145-5p had a better area under the curve of 0.88 [95% confidence interval (CI): 0.784-0.985, < 0.0001] in diagnosing DKD than miR-27a-3p with 0.71 (95%CI: 0.547-0.871, = 0.0239). Bioinformatics analysis revealed that the target genes of miR-145-5p were located in the actin filament, cytoskeleton, and extracellular exosome and were involved in the pathological processes of DKD, including apoptosis, inflammation, and fibrosis. Urinary exosomal miR-145-5p and miR-27a-3p may serve as novel noninvasive diagnostic biomarkers or promising therapeutic targets for DKD.]]></description><identifier>ISSN: 1948-9358</identifier><identifier>EISSN: 1948-9358</identifier><identifier>DOI: 10.4239/wjd.v15.i1.92</identifier><identifier>PMID: 38313849</identifier><language>eng</language><publisher>United States</publisher><ispartof>World journal of diabetes, 2024-01, Vol.15 (1), p.92-104</ispartof><rights>The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3</citedby><cites>FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38313849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Lu-Lu</creatorcontrib><creatorcontrib>Wang, Sheng-Hai</creatorcontrib><creatorcontrib>Yao, Ming-Yan</creatorcontrib><creatorcontrib>Zhou, Hong</creatorcontrib><title>Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease</title><title>World journal of diabetes</title><addtitle>World J Diabetes</addtitle><description><![CDATA[Diabetic kidney disease (DKD), characterized by increased urinary microalbumin levels and decreased renal function, is the primary cause of end-stage renal disease. Its pathological mechanisms are complicated and multifactorial; Therefore, sensitive and specific biomarkers are needed. Urinary exosome originate from diverse renal cells in nephron segments and partially mirror the pathological changes in the kidney. The microRNAs (miRNAs) in urinary exosome are remarkably stable and highly tissue-specific for the kidney. To determine if urinary exosomal miRNAs from diabetic patients can serve as noninvasive biomarkers for early DKD diagnosis. Type 2 diabetic mellitus (T2DM) patients were recruited from the Second Hospital of Hebei Medical University and were divided into two groups: DM, diabetic patients without albuminuria [urinary albumin to creatinine ratio (UACR) < 30 mg/g] and DKD, diabetic patients with albuminuria (UACR ≥ 30 mg/g). Healthy subjects were the normal control (NC) group. Urinary exosomal miR-145-5p, miR-27a-3p, and miR-29c-3p, were detected using real-time quantitative polymerase chain reaction. The correlation between exosomal miRNAs and the clinical indexes was evaluated. The diagnostic values of exosomal miR-145-5p and miR-27a-3p in DKD were determined using receiver operating characteristic (ROC) analysis. Biological functions of miR-145-5p were investigated by performing Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Urinary exosomal expression of miR-145-5p and miR-27a-3p was more upregulated in the DKD group than in the DM group (miR-145-5p: 4.54 ± 1.45 1.95 ± 0.93, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.71 ± 0.76, < 0.05) and the NC group (miR-145-5p: 4.54 ± 1.45 1.55 ± 0.83, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.10 ± 0.51, < 0.001). The exosomal miR-145-5p and miR-27a-3p positively correlated with albuminuria and serum creatinine and negatively correlated with the estimated glomerular filtration rate. miR-27a-3p was also closely related to blood glucose, glycosylated hemoglobin A1c, and low-density lipoprotein cholesterol. ROC analysis revealed that miR-145-5p had a better area under the curve of 0.88 [95% confidence interval (CI): 0.784-0.985, < 0.0001] in diagnosing DKD than miR-27a-3p with 0.71 (95%CI: 0.547-0.871, = 0.0239). Bioinformatics analysis revealed that the target genes of miR-145-5p were located in the actin filament, cytoskeleton, and extracellular exosome and were involved in the pathological processes of DKD, including apoptosis, inflammation, and fibrosis. Urinary exosomal miR-145-5p and miR-27a-3p may serve as novel noninvasive diagnostic biomarkers or promising therapeutic targets for DKD.]]></description><issn>1948-9358</issn><issn>1948-9358</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkElPwzAQhS0EolXpkSvKkUuCtzjxsarYpAokRM_WJHaQ28QpdlvIv8dV2eYyM2-enjQfQpcEZ5wyefOx0tme5JklmaQnaEwkL1PJ8vL03zxC0xBWOBbPhWDyHI1YyQgruRyjYemtAz8k5rMPfQdt0tna9y9Ps5TwPM03CTj9p9ECUha1eptASFzvrNtDsHuTaAtvrg9bWyeVjUF-bXxImt4fLpU56GurnRniHgwEc4HOGmiDmX73CVre3b7OH9LF8_3jfLZIayroNgWSF1ISgSvaAMdAjNE1cEmxZqAF1SUthIG8KQUDrBtcVdDUugCK67Khmk3Q9TF34_v3nQlb1dlQm7YFZ_pdUFRSyrlgtIjW9GiN34bgTaM23sZXBkWwOgBXEbiKwJUlStLov_qO3lWd0b_uH7zsC2LufdE</recordid><startdate>20240115</startdate><enddate>20240115</enddate><creator>Han, Lu-Lu</creator><creator>Wang, Sheng-Hai</creator><creator>Yao, Ming-Yan</creator><creator>Zhou, Hong</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240115</creationdate><title>Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease</title><author>Han, Lu-Lu ; Wang, Sheng-Hai ; Yao, Ming-Yan ; Zhou, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Han, Lu-Lu</creatorcontrib><creatorcontrib>Wang, Sheng-Hai</creatorcontrib><creatorcontrib>Yao, Ming-Yan</creatorcontrib><creatorcontrib>Zhou, Hong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Lu-Lu</au><au>Wang, Sheng-Hai</au><au>Yao, Ming-Yan</au><au>Zhou, Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease</atitle><jtitle>World journal of diabetes</jtitle><addtitle>World J Diabetes</addtitle><date>2024-01-15</date><risdate>2024</risdate><volume>15</volume><issue>1</issue><spage>92</spage><epage>104</epage><pages>92-104</pages><issn>1948-9358</issn><eissn>1948-9358</eissn><abstract><![CDATA[Diabetic kidney disease (DKD), characterized by increased urinary microalbumin levels and decreased renal function, is the primary cause of end-stage renal disease. Its pathological mechanisms are complicated and multifactorial; Therefore, sensitive and specific biomarkers are needed. Urinary exosome originate from diverse renal cells in nephron segments and partially mirror the pathological changes in the kidney. The microRNAs (miRNAs) in urinary exosome are remarkably stable and highly tissue-specific for the kidney. To determine if urinary exosomal miRNAs from diabetic patients can serve as noninvasive biomarkers for early DKD diagnosis. Type 2 diabetic mellitus (T2DM) patients were recruited from the Second Hospital of Hebei Medical University and were divided into two groups: DM, diabetic patients without albuminuria [urinary albumin to creatinine ratio (UACR) < 30 mg/g] and DKD, diabetic patients with albuminuria (UACR ≥ 30 mg/g). Healthy subjects were the normal control (NC) group. Urinary exosomal miR-145-5p, miR-27a-3p, and miR-29c-3p, were detected using real-time quantitative polymerase chain reaction. The correlation between exosomal miRNAs and the clinical indexes was evaluated. The diagnostic values of exosomal miR-145-5p and miR-27a-3p in DKD were determined using receiver operating characteristic (ROC) analysis. Biological functions of miR-145-5p were investigated by performing Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Urinary exosomal expression of miR-145-5p and miR-27a-3p was more upregulated in the DKD group than in the DM group (miR-145-5p: 4.54 ± 1.45 1.95 ± 0.93, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.71 ± 0.76, < 0.05) and the NC group (miR-145-5p: 4.54 ± 1.45 1.55 ± 0.83, < 0.001; miR-27a-3p: 2.33 ± 0.79 1.10 ± 0.51, < 0.001). The exosomal miR-145-5p and miR-27a-3p positively correlated with albuminuria and serum creatinine and negatively correlated with the estimated glomerular filtration rate. miR-27a-3p was also closely related to blood glucose, glycosylated hemoglobin A1c, and low-density lipoprotein cholesterol. ROC analysis revealed that miR-145-5p had a better area under the curve of 0.88 [95% confidence interval (CI): 0.784-0.985, < 0.0001] in diagnosing DKD than miR-27a-3p with 0.71 (95%CI: 0.547-0.871, = 0.0239). Bioinformatics analysis revealed that the target genes of miR-145-5p were located in the actin filament, cytoskeleton, and extracellular exosome and were involved in the pathological processes of DKD, including apoptosis, inflammation, and fibrosis. Urinary exosomal miR-145-5p and miR-27a-3p may serve as novel noninvasive diagnostic biomarkers or promising therapeutic targets for DKD.]]></abstract><cop>United States</cop><pmid>38313849</pmid><doi>10.4239/wjd.v15.i1.92</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-9358
ispartof World journal of diabetes, 2024-01, Vol.15 (1), p.92-104
issn 1948-9358
1948-9358
language eng
recordid cdi_proquest_miscellaneous_2922446327
source PubMed Central
title Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T23%3A06%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urinary%20exosomal%20microRNA-145-5p%20and%20microRNA-27a-3p%20act%20as%20noninvasive%20diagnostic%20biomarkers%20for%20diabetic%20kidney%20disease&rft.jtitle=World%20journal%20of%20diabetes&rft.au=Han,%20Lu-Lu&rft.date=2024-01-15&rft.volume=15&rft.issue=1&rft.spage=92&rft.epage=104&rft.pages=92-104&rft.issn=1948-9358&rft.eissn=1948-9358&rft_id=info:doi/10.4239/wjd.v15.i1.92&rft_dat=%3Cproquest_cross%3E2922446327%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c262t-a15799160b2fa40a1eedca4920d3ad62d8276ea5f863a0df0bbafcd7a20c8f2d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2922446327&rft_id=info:pmid/38313849&rfr_iscdi=true